Correlation Between Indaptus Therapeutics and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indaptus Therapeutics and Aerovate Therapeutics, you can compare the effects of market volatilities on Indaptus Therapeutics and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and Aerovate Therapeutics.
Diversification Opportunities for Indaptus Therapeutics and Aerovate Therapeutics
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Indaptus and Aerovate is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Indaptus Therapeutics and Aerovate Therapeutics
Given the investment horizon of 90 days Indaptus Therapeutics is expected to generate 1.75 times more return on investment than Aerovate Therapeutics. However, Indaptus Therapeutics is 1.75 times more volatile than Aerovate Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Aerovate Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 85.00 in Indaptus Therapeutics on November 2, 2024 and sell it today you would earn a total of 7.00 from holding Indaptus Therapeutics or generate 8.24% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Indaptus Therapeutics vs. Aerovate Therapeutics
Performance |
| Timeline |
| Indaptus Therapeutics |
| Aerovate Therapeutics |
Indaptus Therapeutics and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Indaptus Therapeutics and Aerovate Therapeutics
The main advantage of trading using opposite Indaptus Therapeutics and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
| Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |